by Xcellerant Ventures | Jan 16, 2024 | Portfolio Company News
Origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/dr-ghassan-kassab-joins-anuncia-medicals-board-elevating-future-product-innovation-302035828.html SCOTTSDALE, Ariz., Jan. 16, 2024 /PRNewswire/ — Anuncia Medical Inc....
by Xcellerant Ventures | Jan 12, 2024 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in CRISPR QC The Xcellerant Venture’s team is proud to lead a Series A funding round for CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first and only CRISPR Analytics Platform. This platform...
by Xcellerant Ventures | Jan 6, 2024 | Xcellerant Ventures News
Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240105587000/en/Xcellerant-Ventures-Ends-First-Year-with-10th-Investment-Leading-CRISPR-QC%E2%80%99s-10-Million-Series-A-Round SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant...
by Xcellerant Ventures | Jan 5, 2024 | Portfolio Company News
Originally posted on Business Wire: https://www.businesswire.com/news/home/20240104480597/en/Xcellerant-Ventures-Backs-CRISPR-QC-in-Series-A-and-Commercial-Expansion SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a biotechnology start-up based in San Diego, is...
by Xcellerant Ventures | Dec 20, 2023 | Portfolio Company News, Xcellerant Ventures News
Why Xcellerant Ventures Invested in Lenoss Medical The Xcellerant Venture’s team proudly welcomes Lenoss Medical as our 9th portfolio company in Xcellerant Ventures Fund 1. The enthusiasm surrounding their groundbreaking technology is nothing short of exhilarating. In...
